Targeted Activation of Human Vγ9Vδ2-T Cells Controls Epstein-Barr Virus-Induced B Cell Lymphoproliferative Disease

被引:119
|
作者
Xiang, Zheng [1 ]
Liu, Yinping [1 ]
Zheng, Jian [1 ]
Liu, Ming [2 ]
Lv, Aizhen [1 ]
Gao, Yulong [1 ]
Hu, Huaidong [3 ]
Lam, Kowk-Tai [1 ]
Chan, Godfrey Chi-Fung [1 ]
Yang, Yuanzhong [4 ]
Chen, Honglin [5 ]
Tsao, George Sai-Wah [6 ]
Bonneville, Marc [7 ,8 ]
Lau, Yu-Lung [1 ]
Tu, Wenwei [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China
[2] Guangzhou Med Univ, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 2, Minist Educ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China
[5] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[6] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China
[7] Univ Nantes, Ctr Rech Cancerol Nantes Angers, F-44300 Nantes, France
[8] INSERM U892 CNRS UMR6299, F-44300 Nantes, France
关键词
DELTA-T-CELLS; GAMMA-DELTA; EBV INFECTION; LYMPHOCYTES; EXPRESSION; MICE; PHOSPHOANTIGEN; IMMUNOTHERAPY; CYTOTOXICITY; STIMULATION;
D O I
10.1016/j.ccr.2014.07.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epstein-Barr virus-induced lymphoproliferative disease (EBV-LPD) after transplantation remains a serious and life-threatening complication. Herein we showed that the aminobisphosphonate pamidronate-expanded human V gamma 9V delta 2-T cells efficiently killed EBV-transformed autologous lymphoblastoid B cell lines (EBV-LCL) through gamma/delta-TCR and NKG2D receptor triggering and Fas and TRAIL engagement. By inoculation of EBV-LCL in Rag2(-/-)gamma C-/- mice and humanized mice, we established lethal EBV-LPD with characteristics close to those of the human disease. Adoptive transfer of pamidronate-expanded V gamma 9V delta 2-T cells alone effectively prevented EBV-LPD in Rag2(-/-)gamma C-/- mice and induced EBV-LPD regression in EBV+ tumor-bearing Rag2-/-yc-/- mice. Pamidronate treatment inhibited EBV-LPD development in humanized mice through selective activation and expansion of V gamma 9V delta 2-T cells. This study provides proof-of-principle for a therapeutic approach using pamidronate to control EBV-LPD through V gamma 9V delta 2-T cell targeting.
引用
收藏
页码:565 / 576
页数:12
相关论文
共 50 条
  • [1] Exosomes derived from human Vγ9Vδ2-T cells exert therapeutic effects on Epstein-Barr virus-induced B cell lymphoproliferative disease
    Wang, X.
    Liu, Y.
    Xiang, Z.
    Wen, K.
    Pei, Y.
    Mu, X.
    Tu, W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 448 - 449
  • [2] Statins prevent bisphosphonate-induced Vγ9Vδ2-T cell activation and proliferation in vitro
    Thompson, K
    Rogers, MJ
    BONE, 2004, 34 : S72 - S73
  • [3] HLA LINKED SUPPRESSION OF EPSTEIN-BARR VIRUS-INDUCED B-CELL ACTIVATION BY T-CELLS
    TOSATO, G
    SHAW, S
    BLAESE, RM
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 1161 - 1161
  • [4] MECHANISM OF EPSTEIN-BARR VIRUS-INDUCED HUMAN LYMPHOCYTE-B ACTIVATION
    SCHOOLEY, RT
    HAYNES, BF
    PAYLINGWRIGHT, CR
    GROUSE, JE
    DOLIN, R
    FAUCI, AS
    CELLULAR IMMUNOLOGY, 1980, 56 (02) : 518 - 525
  • [5] Human Vγ9Vδ2-T cells efficiently kill influenza virus-infected lung alveolar epithelial cells
    Hong Li
    Zheng Xiang
    Ting Feng
    Jinrong Li
    Yinping Liu
    Yingying Fan
    Qiao Lu
    Zhongwei Yin
    Meixing Yu
    Chongyang Shen
    Wenwei Tu
    Cellular & Molecular Immunology, 2013, 10 : 159 - 164
  • [6] Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy
    Werter, Inge M.
    Schneiders, Famke L.
    Scotet, Emmanuel
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    ONCOIMMUNOLOGY, 2014, 3 (09)
  • [7] Acquisition of antigen presenting cell functions by Vγ9Vα2-T cells requires trogocytosis
    Schneiders, Famke L.
    Santegoets, Saskia J. A. M.
    Scheper, Rik J.
    Verheul, Henk M. W.
    Bonneville, Marc
    Scotet, Emmanuel
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    CANCER RESEARCH, 2012, 72
  • [8] Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody
    de Bruin, Renee C. G.
    Stam, Anita G. M.
    Vangone, Anna
    Henegouwen, Paul M. P. van Bergen en
    Verheul, Henk M. W.
    Sebestyen, Zsolt
    Kuball, Jurgen
    Bonvin, Alexandre M. J. J.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01): : 308 - 317
  • [9] THE EPSTEIN-BARR VIRUS-INDUCED PRODUCTION OF IGE BY HUMAN B-CELLS
    MARTINEZMAZA, O
    GUILBERT, B
    DAVID, B
    AVRAMEAS, S
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 39 (03): : 405 - 413
  • [10] Human Vγ9Vδ2-T cells efficiently kill influenza virus-infected lung alveolar epithelial cells
    Li, Hong
    Xiang, Zheng
    Feng, Ting
    Li, Jinrong
    Liu, Yinping
    Fan, Yingying
    Lu, Qiao
    Yin, Zhongwei
    Yu, Meixing
    Shen, Chongyang
    Tu, Wenwei
    CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (02) : 159 - 164